Our central hypothesis is that involutional osteoporosis in women is heterogeneous and results from impaired production of, or response to, several systemic and local regulatory factors. We have four specific aims covered by 12 interrelated protocols.
Specific Aim 1 : to characterize the short-term patterns of bone turnover (by measuring biochemical markers) in normal and osteoporotic women and the regulatory factors responsible for these patterns. We will assess day/night patterns of bone turnover, determine if the nocturnal decrease in bone formation depends on growth hormone, determine if the apparent nocturnal increase in bone resorption in osteoporotic women depends on parathyroid hormone (PTH) or prostaglandins, and search for evidence of functionally different osteoblast populations.
Specific Aim 2 : to elucidate the pathophysiology of type I osteoporosis more completely by searching for the interaction of estrogen deficiency with other factors that predispose some, but not other, postmenopausal women to osteoporosis. Possible factors include increased sensitivity of the bone to PTH actin, decreased concentration of sex steroid receptors, and impaired production of, or response to, local growth factors.
specific Aim 3 : to evaluate the contribution of resistance to 1,25-dihydroxyvitamin D (1,25(OH2D) action to abnormal calcium (Ca) homeostasis in elderly women. Our preliminary data suggest tat this, rather than decreased 1,250(OH)2D treatment, in concentrations of 1,25(OH)2D receptors or postreceptor responses, and in feedback regulation of PTH secretion by 1,25(OH)2D.
Specific Aim 4 : to define other pathogenetic mechanisms for the development of age-related bone loss and type II osteoporosis. We will evaluate age-related changes in the actions of estrogen and PTH on bone, in systemic hormone concentrations, in estrogen receptor concentrations in cultured human bone cells and in the response of these cells to growth factors. We have available virtually all methodologies for clinical investigation of osteoporosis including several new state- of-the-art ones. These studies should lead to a better understanding of etiology and pathophysiology of involutional osteoporosis and, ultimately, to better ways of preventing and treating it.
| Kattah, Andrea G; Smith, Carin Y; Gazzuola Rocca, Liliana et al. (2018) CKD in Patients with Bilateral Oophorectomy. Clin J Am Soc Nephrol 13:1649-1658 |
| Khosla, Sundeep; Monroe, David G (2018) Regulation of Bone Metabolism by Sex Steroids. Cold Spring Harb Perspect Med 8: |
| Bower, James H; Grossardt, Brandon R; Rocca, Walter A et al. (2018) Prevalence of and indications for antipsychotic use in Parkinson's disease. Mov Disord 33:325-328 |
| Rocca, Walter A; Grossardt, Brandon R; Brue, Scott M et al. (2018) Data Resource Profile: Expansion of the Rochester Epidemiology Project medical records-linkage system (E-REP). Int J Epidemiol 47:368-368j |
| Xu, Ming; Pirtskhalava, Tamar; Farr, Joshua N et al. (2018) Senolytics improve physical function and increase lifespan in old age. Nat Med 24:1246-1256 |
| Khosla, Sundeep; Farr, Joshua N; Kirkland, James L (2018) Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis. J Clin Endocrinol Metab 103:1282-1290 |
| Rocca, Walter A (2018) The future burden of Parkinson's disease. Mov Disord 33:8-9 |
| Rocca, Walter A; Gazzuola Rocca, Liliana; Smith, Carin Y et al. (2018) Personal, reproductive, and familial characteristics associated with bilateral oophorectomy in premenopausal women: A population-based case-control study. Maturitas 117:64-77 |
| Drake, Matthew T; Fenske, Jennifer S; Blocki, Frank A et al. (2018) Validation of a novel, rapid, high precision sclerostin assay not confounded by sclerostin fragments. Bone 111:36-43 |
| Laughlin-Tommaso, Shannon K; Khan, Zaraq; Weaver, Amy L et al. (2018) Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study. Menopause 25:483-492 |
Showing the most recent 10 out of 401 publications
